daratumumab and hyaluronidase

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-traditional-approval-daratumumab-and-hyaluronidase-fihj-newly-diagnosed-light-chain FDA grants traditional approval to daratumumab and hyaluronidase-fihj for newly diagnosed light... On November 19, 2025, the Food and Drug Administration granted traditional approval to daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech... daratumumab and hyaluronidase https://www.aacr.org/patients-caregivers/progress-against-cancer/a-new-multiple-myeloma-indication-for-daratumumab-and-hyaluronidase-fihj/ A New Multiple Myeloma Indication for Daratumumab and Hyaluronidase-fihj | Research | Blog Aug 30, 2024 - Daratumumab and hyaluronidase-fihj with bortezomib, lenalidomide, and dexamethasone was approved for some patients with multiple myeloma. daratumumab and hyaluronidase multiple myeloma https://www.einpresswire.com/article/887001812/fda-approves-daratumumab-and-hyaluronidase-fihj-with-bortezomib-lenalidomide-and-dexamethasone-for-newly-diagnosed-multiple-myeloma FDA approves daratumumab and hyaluronidase-fihj with bortezomib, lenalidomide, and dexamethasone... Jan 27, 2026 - On January 27, 2026, the Food and Drug Administration approved daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) in combination with daratumumab and hyaluronidase fda approves bortezomib lenalidomide https://www.hmpgloballearningnetwork.com/site/onc/fda-alerts/fda-grants-approval-daratumumab-and-hyaluronidase-bortezomib-lenalidomide-and FDA Grants Approval to Daratumumab and Hyaluronidase With Bortezomib, Lenalidomide, and... On January 27, 2026, the FDA granted approval to daratumumab and hyaluronidase-fihj in combination with bortezomib, lenalidomide, and dexamethasone (VRd) for... daratumumab and hyaluronidase fda grants approval bortezomib

Robuta